Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia

[1]  R. Vierkant,et al.  Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women , 2016, Cancer.

[2]  Kenneth Offit,et al.  Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  I. Bedrosian,et al.  Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia , 2016, Annals of Surgical Oncology.

[4]  J. Cuzick,et al.  Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial , 2014, The Lancet.

[5]  Derek C. Radisky,et al.  Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study , 2014, Cancer Prevention Research.

[6]  Mark A Helvie,et al.  Does digital mammography increase detection of high-risk breast lesions presenting as calcifications? , 2013, AJR. American journal of roentgenology.

[7]  Karla Kerlikowske,et al.  Benign breast disease, mammographic breast density, and the risk of breast cancer. , 2013, Journal of the National Cancer Institute.

[8]  H. Gilbert Welch,et al.  Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence , 2013 .

[9]  A. Degnim,et al.  Surgical management of high-risk breast lesions. , 2013, The Surgical clinics of North America.

[10]  W. Han,et al.  Validation of a Scoring System for Predicting Malignancy in Patients Diagnosed with Atypical Ductal Hyperplasia Using an Ultrasound-Guided Core Needle Biopsy , 2012, Journal of breast cancer.

[11]  Anthony J. Guidi,et al.  The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions , 2012, Breast Cancer Research and Treatment.

[12]  B. Pockaj,et al.  Atypical Ductal Hyperplasia on Core Biopsy: An Automatic Trigger for Excisional Biopsy? , 2012, Annals of Surgical Oncology.

[13]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[14]  Karen A Gelmon,et al.  Exemestane for breast-cancer prevention in postmenopausal women. , 2011, The New England journal of medicine.

[15]  J. Robert,et al.  Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy. , 2011, Breast.

[16]  Wendy B DeMartini,et al.  Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. , 2011, Human pathology.

[17]  N. Sneige,et al.  Atypical Ductal Hyperplasia in Directional Vacuum-Assisted Biopsy of Breast Microcalcifications: Considerations for Surgical Excision , 2011, Annals of Surgical Oncology.

[18]  M. Pearlman,et al.  Benign Breast Disease , 2010, Obstetrics and gynecology.

[19]  Wendy B DeMartini,et al.  Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. , 2010, Radiology.

[20]  Joseph P. Costantino,et al.  Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer , 2010, Cancer Prevention Research.

[21]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[22]  G. Acs,et al.  Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. , 2009, American journal of clinical pathology.

[23]  K. Chin,et al.  Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ , 2009, BMC Cancer.

[24]  I. Treilleux,et al.  Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. , 2008, American journal of surgery.

[25]  R. Birdwell.  Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised? , 2008 .

[26]  W. Han,et al.  Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy , 2008, Breast Cancer Research and Treatment.

[27]  R. Vierkant,et al.  Stratification of breast cancer risk in women with atypia: a Mayo cohort study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  S. van Buuren.  Multiple imputation of discrete and continuous data by fully conditional specification , 2007, Statistical methods in medical research.

[29]  L. Ford,et al.  Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.

[30]  V Shane Pankratz,et al.  Benign breast disease and the risk of breast cancer. , 2005, The New England journal of medicine.

[31]  A. Cruz,et al.  Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. , 2009, Archives of pathology & laboratory medicine.

[32]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[33]  Terry L. Smith,et al.  Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. , 2003, American journal of clinical pathology.

[34]  D. Ikeda,et al.  Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? , 2002, Radiology.

[35]  D. Page,et al.  Core Biopsy of the Breast With Atypical Ductal Hyperplasia: A Probabilistic Approach to Reporting , 2001, The American journal of surgical pathology.

[36]  G. Colditz,et al.  Pathologic features of breast cancers in women with previous benign breast disease. , 2001, American journal of clinical pathology.

[37]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[38]  W D Dupont,et al.  Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.

[39]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.